Neoplasie vescicali

1. Ruolo dei markers di metilazione nella prognosi delle recidive del carcinoma vescicale

   Roberta Gunelli¹, Valentina Casadio², Massimo Fiori¹, Daniele Calistri², Wainer Zoli²

   • ¹ UO Urologia - OC G.B.Morgagni - AUSL Forlì (Forlì)
   • ² laboratorio di bioscienze IRST (istituto scientifico romagnolo per la cura dei tumori) Meldola (Meldola)

2. PAPILLARY UROTHELIAL NEOPLASM OF LOW MALIGNANT POTENTIAL (PUNLMP): OUR LONG TERM EXPERIENCE

   Roberto Giulianelli¹, Luca Albanesi¹, Francesco Attisani¹, Barbara Cristina Gentile¹, David Granata¹, Luca Mavilla¹, Gabriella Mirabile¹, Manlio Schettini¹, Teuta Shestani¹, Giorgio Vincenti¹, Francesco Pisanti¹, Luca Albanesi¹

   • ¹ Roman Urological Association - Nuova Villa Claudia (Roma)

3. NBI Re-TURB in T1HG TCC: recurrence and progression rate.

   Roberto Giulianelli¹, Luca Albanesi¹, Francesco Attisani¹, Barbara Cristina Gentile¹, David Granata¹, Luca Mavilla¹, Gabriella Mirabile¹, Manlio Schettini¹, Teuta Shestani¹, Giorgio Vincenti¹, Francesco Pisanti¹

   • ¹ Roman Urological Association - Nuova Villa Claudia (Roma)

4. NBI Bipolar TURB:does it improve detection and re-treatment rates? Preliminary single-centre experience

   Roberto Giulianelli¹, Luca Albanesi¹, Francesco Attisani¹

   • ¹ Roman Urological Association - Nuova Villa Claudia (Roma)

5. Bipolar TURB NBI assisted: does it improve detection and re-treatment rates? Preliminary single-centre experience

   Roberto Giulianelli¹, Luca Albanesi¹, Francesco Attisani¹, Barbara Cristina Gentile¹, David Granata¹, Luca Mavilla¹, Gabriella Mirabile¹, Manlio Schettini¹, Teuta Shestani¹, Giorgio Vincenti¹, Francesco Pisanti¹, Luca Albanesi¹

   • ¹ Roman Urological Association - Nuova Villa Claudia (Roma)

7. IS ONCOLOGICAL SAFE PERFORMING SIMULTANEOUS TRANS-URETHRAL RESECTION OF THE BLADDER AND PROSTATE? A META-ANALYSIS ON 1234 PATIENTS

   Stefano Picozzi¹, Stefano Casellato¹, Cristian Ricci², Giorgio Bozzini¹, Serena Maruccia¹, Luca Carmignani¹

   • ¹ IRCCS Policlinico San Donato (San Donato Milanese)
   • ² Biometry and Clinical Epidemiology Unit, Fondazione C. Gnocchi (Milano)

8. Stage Specific Impact of Extended Versus Standard Pelvic Lymph Node Dissection in Radical Cystectomy

   Giuseppe Simone¹, Rocco Papalia¹, Mariaconsiglia Ferriero¹, Salvatore Guaglianone¹, Devis Collura², Emanuele Castelli², Giovanni Muto², Michele Gallucci¹

   • ¹ "Regina Elena" National Cancer Institute (Roma)
   • ² "San Giovanni Bosco" Hospital (Turin)

9. Extended versus Super-extended PLND during Radical cystectomy: Comparison of two prospective series

   Giuseppe Simone¹, Hassan Abol Enein², Rocco Papalia¹, Mariaconsiglia Ferriero¹, Salvatore Guaglianone¹, Mohamed Ghoneim², Michele Gallucci¹

   • ¹ "Regina Elena" National Cancer Institute (Roma)
   • ² Mansoura Urology and Nephrology Centre, Mansoura University (Mansoura, Egypt)

10. Lymph Node Density is the strongest predictor of Cancer Specific Survival in node positive patients treated with Radical Cystectomy

    Giuseppe Simone¹, Hassan Abol Enein², Rocco Papalia¹, Mariaconsiglia Ferriero¹, Salvatore Guaglianone³, Mohamed Ghoneim², Michele Gallucci¹

    • ¹ "Regina Elena" National Cancer Institute (Roma)
    • ² Mansoura Urology and Nephrology Centre, Mansoura University (Mansoura, Egypt)
    • ³ "Regina Elena" Nartional Cancer Institute (Roma)

11. Predictive model of disease free survival after radical cystectomy

    Giuseppe Simone¹, Rocco Papalia¹, Mariaconsiglia Ferriero¹, Salvatore Guaglianone¹, Devis Collura², Rodolfo Rosso², Giovanni Muto², Michele Gallucci¹

    • ¹ "Regina Elena" National Cancer Institute (Roma)
    • ² "San Giovanni Bosco" Hospital (Turin)